Erlocip (ERLOTINIB 100 mg) x 30 Tablets

Uses of ERLOTINIB 100 mg

• Treats non-small cell lung cancer (NSCLC).
• Used for advanced pancreatic cancer.
• Effective in EGFR-positive cancers.
• Helps slow cancer progression.

Benefits of ERLOTINIB 100 mg

• Targets cancer cells specifically.
• Slows tumor growth and spread.
• May improve progression-free survival.
• Helps relieve cancer-related symptoms.
• Convenient oral tablet taken at home.
• May reduce the need for frequent hospital visits.
• Can be effective after certain previous treatments.
• Supports personalized treatment for EGFR-positive cancers.
• May help maintain quality of life during treatment.

How Does It Work?

Erlotinib is a targeted anticancer medicine known as an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor. It works by blocking the signals that tell cancer cells to grow and divide. By inhibiting the EGFR protein, Erlotinib slows or stops the growth of cancer cells and may help shrink tumors or delay their progression.

Precautions

• Take on an empty stomach.
• Avoid smoking during treatment.
• Monitor liver function regularly.
• Report breathing or vision problems immediately.
• Avoid pregnancy and breastfeeding.
• Use only under medical supervision.

Side effects

• Rash or skin irritation
• Diarrhea
• Fatigue or weakness
• Nausea or vomiting
• Loss of appetite
• Shortness of breath
• Eye irritation or dryness

Buy Erlocip Erlotinib 100 mg Tablets in bulk at competitive prices

Order Erlocip Erlotinib 100 mg Tablets from our licensed international pharmacy. We provide genuine generic oncology medicines in bulk to patients, doctors, hospitals, clinics, and healthcare professionals across multiple countries, including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Egypt, Cyprus, Iraq, Iran, Jordan, Israel, Qatar, Palestine, Saudi Arabia, the United Arab Emirates, Russia, Canada, Brazil, Mexico, China, Thailand, Singapore, Malaysia, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.